OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
Shuling Chen, Yubin Xie, Yuhong Cai, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 9, pp. 1896-1910
Open Access | Times Cited: 45
Shuling Chen, Yubin Xie, Yuhong Cai, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 9, pp. 1896-1910
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 90
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 90
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences
Shuling Chen, Cheng Huang, Guanrui Liao, et al.
Gut (2023) Vol. 72, Iss. 6, pp. 1196-1210
Open Access | Times Cited: 35
Shuling Chen, Cheng Huang, Guanrui Liao, et al.
Gut (2023) Vol. 72, Iss. 6, pp. 1196-1210
Open Access | Times Cited: 35
Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
Zhihang Chen, Guopei Zhang, Xiaoxue Ren, et al.
Cancer Research (2023) Vol. 83, Iss. 21, pp. 3544-3561
Closed Access | Times Cited: 30
Zhihang Chen, Guopei Zhang, Xiaoxue Ren, et al.
Cancer Research (2023) Vol. 83, Iss. 21, pp. 3544-3561
Closed Access | Times Cited: 30
Omics-based deep learning approaches for lung cancer decision-making and therapeutics development
Thi-Oanh Tran, Thanh Hoa Vo, Nguyen Quoc Khanh Le
Briefings in Functional Genomics (2023) Vol. 23, Iss. 3, pp. 181-192
Closed Access | Times Cited: 30
Thi-Oanh Tran, Thanh Hoa Vo, Nguyen Quoc Khanh Le
Briefings in Functional Genomics (2023) Vol. 23, Iss. 3, pp. 181-192
Closed Access | Times Cited: 30
Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer
Junyu Li, Lin Li, Peimeng You, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 35-49
Closed Access | Times Cited: 29
Junyu Li, Lin Li, Peimeng You, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 35-49
Closed Access | Times Cited: 29
Development and validation of a new prognostic immune–inflammatory–nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study
Jiang Zhu, Denghui Wang, Chang Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Jiang Zhu, Denghui Wang, Chang Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Th17 Cells Secrete TWEAK to Trigger Epithelial–Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis
Xin Liu, Xin Wang, Qingxia Yang, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1352-1371
Closed Access | Times Cited: 15
Xin Liu, Xin Wang, Qingxia Yang, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1352-1371
Closed Access | Times Cited: 15
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma
Lixia Xu, Ying Zhang, Zhilong Lin, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 265-277
Closed Access | Times Cited: 13
Lixia Xu, Ying Zhang, Zhilong Lin, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 265-277
Closed Access | Times Cited: 13
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma
Sirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Sirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma
Lu Chen, Guotao Yin, Ziyang Wang, et al.
BioScience Trends (2024) Vol. 18, Iss. 3, pp. 263-276
Open Access | Times Cited: 5
Lu Chen, Guotao Yin, Ziyang Wang, et al.
BioScience Trends (2024) Vol. 18, Iss. 3, pp. 263-276
Open Access | Times Cited: 5
DriverDBv4: a multi-omics integration database for cancer driver gene research
Chia-Hsin Liu, Yo-Liang Lai, Pei-Chun Shen, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1246-D1252
Open Access | Times Cited: 12
Chia-Hsin Liu, Yo-Liang Lai, Pei-Chun Shen, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1246-D1252
Open Access | Times Cited: 12
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Integrating multiomics analysis and machine learning to refine the molecular subtyping and prognostic analysis of stomach adenocarcinoma
Miaodong Wang, Qin He, Zeshan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Miaodong Wang, Qin He, Zeshan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Advanced intrahepatic cholangiocarcinoma successfully treated with combined immunotherapy: focusing on the tumor immune microenvironment
Mitsuyoshi Omoto, Katsutoshi Sugimoto, Yutaka Kurebayashi, et al.
Clinical Journal of Gastroenterology (2025)
Open Access
Mitsuyoshi Omoto, Katsutoshi Sugimoto, Yutaka Kurebayashi, et al.
Clinical Journal of Gastroenterology (2025)
Open Access
Heterogeneity of small duct‐ and large duct‐type intrahepatic cholangiocarcinoma
Maximilian N. Kinzler, Falko Schulze, Jan Jeroch, et al.
Histopathology (2024) Vol. 84, Iss. 6, pp. 1061-1067
Open Access | Times Cited: 3
Maximilian N. Kinzler, Falko Schulze, Jan Jeroch, et al.
Histopathology (2024) Vol. 84, Iss. 6, pp. 1061-1067
Open Access | Times Cited: 3
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Cost-effectiveness analysis of Pembrolizumab combined with gemcitabine and cisplatin for the first-line treatment for advanced cholangiocarcinoma
Wei Wang, Lijun Xu, Peilin Li, et al.
Heliyon (2025), pp. e42553-e42553
Open Access
Wei Wang, Lijun Xu, Peilin Li, et al.
Heliyon (2025), pp. e42553-e42553
Open Access
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
Michael S. Oh, Jensen Abascal, Austin K. Rennels, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1027-1027
Open Access
Michael S. Oh, Jensen Abascal, Austin K. Rennels, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1027-1027
Open Access
Factors Contributing to the High Malignancy Level of Cholangiocarcinoma and Its Epidemiology: Literature Review and Data
Xuan Li, Renchu Guan, Shuangquan Zhang
Biology (2025) Vol. 14, Iss. 4, pp. 351-351
Open Access
Xuan Li, Renchu Guan, Shuangquan Zhang
Biology (2025) Vol. 14, Iss. 4, pp. 351-351
Open Access
Targeting of COPⅠ elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma
Zehong Chen, Guiqin Xu, Xu Chen, et al.
Cancer Letters (2025), pp. 217786-217786
Closed Access
Zehong Chen, Guiqin Xu, Xu Chen, et al.
Cancer Letters (2025), pp. 217786-217786
Closed Access
Single-Cell Sequencing and Its Applications in Liver Cancer
Binle Tian, Qi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Binle Tian, Qi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions
Sudha Kodali, Ashton A. Connor, Souhail Thabet, et al.
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 2, pp. 129-138
Closed Access | Times Cited: 9
Sudha Kodali, Ashton A. Connor, Souhail Thabet, et al.
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 2, pp. 129-138
Closed Access | Times Cited: 9
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how
Pablo Achurra, Eduardo de Souza Martins Fernandes, Grainne M. O’Kane, et al.
Current Opinion in Organ Transplantation (2024) Vol. 29, Iss. 2, pp. 161-171
Closed Access | Times Cited: 3
Pablo Achurra, Eduardo de Souza Martins Fernandes, Grainne M. O’Kane, et al.
Current Opinion in Organ Transplantation (2024) Vol. 29, Iss. 2, pp. 161-171
Closed Access | Times Cited: 3
